info icon

This is a non-core endpoint: only basic statistics are computed.

See its core counterpart CD2_INSITU_RESPNOS_EXALLC for full statistics.

Carcinoma in situ of respiratory system, other/unspecified

CD2_INSITU_RESPNOS

No definition available.

Endpoint definition

FinnGen phenotype data

429209 individuals

diagram downward connector

Apply sex-specific rule None

429209

diagram downward connector

Check conditions None

429209

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, registry filters

Hospital Discharge: ICD-10 D02.3&, D02.4&
Hospital discharge: ICD-9 231[8-9]
Cause of death: ICD-10 D02.3&, D02.4&
Cause of death: ICD-9 231[8-9]

2 out of 7 registries used, show all original rules.

16

diagram downward connector

Check minimum number of events None

16

diagram downward connector

Include endpoints None

16

diagram downward connector
diagram bullet diagram downward connector

Remove individuals based on genotype QC

16

diagram downward connector
CD2_INSITU_RESPNOS

Control definitions

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy 3
First used in FinnGen datafreeze DF2

Similar endpoints

List of similar endpoints to Carcinoma in situ of respiratory system, other/unspecified based on the number of shared cases.

Venn diagram with an highlighted set fully inside another set Broader endpoints:

Venn diagram with a set fully inside an highlighted set Narrower endpoints:

Show all endpoint correlations

Summary Statistics

Key figures

All Female Male
Number of individuals 16 - 12
Unadjusted prevalence (%) 0.00 - 0.01
Mean age at first event (years) 67.38 - 69.79

Mortality

Not a core endpoint, no data to show.

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Not a core endpoint, no data to show.

Correlations

Index endpoint: CD2_INSITU_RESPNOS – Carcinoma in situ of respiratory system, other/unspecified
GWS hits:

Survival analyses between endpoints

Not a core endpoint, no data to show.

Drugs most likely to be purchased after Carcinoma in situ of respiratory system, other/unspecified

Endpoint not on priority list, no data to show.